Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05345002
Title All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Stephen Bagley, MD, MSCE
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST